Discovery of YK-029A, a novel mutant EGFR inhibitor targeting both T790 M and exon 20 insertion mutations, as a treatment for NSCLC
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 5 October 2023 258 - Subject
- Language
- ISSN
- 0223-5234